Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - PRE-TAX INCOME
Pre-tax Income ABUS - Arbutus Biopharma Corporation
-72.8 M
LAST VALUE
2.25%
2 YEAR CAGR
-3.48%
5 YEAR CAGR
-17.88%
10 YEAR CAGR